Ask Us
Register
Monitoring Medicines for over 2,574,000 Members
Australia
Brasil
Deutschland
España
France
United Kingdom
United States
English
Español
What is MediGuard?
Drugs A to Z
Conditions
Research
About Us
Recent Pages:
Amaryl satisfaction and usage data | Monitoring more than 6,200 patients | Drug safety information
/
Drug Alerts For Risperidone
/
Canasa satisfaction and usage data | Monitoring more than 6,000 patients | Drug safety information
Please correct the highlighted fields below.
Alerts for
Ezetimibe with Simvastatin
Title
Date Published
Source
Las Estatinas Relacionadas Con Un Aumento De Azúcar En Sangre Y Diabetes En Algunos Pacientes
2012-01-27
Statins Linked to Raised Blood Sugar and Diabetes in Some Patients
2012-01-16
FDA Revises Dose Limitation for Zocor (simvastatin) When Taken with Amiodarone
2011-12-15
TGA Recommends Dose Limits for Simvastatin
2011-12-05
Neue Studie legt das Auftreten von Diabetes durch Behandlung mit Statinen nahe
2011-07-07
Une nouvelle étude suggère que les statines à dose élevée peuvent causer un diabète
2011-07-06
Un Nuevo Estudio Propone Que Dosis Altas De Estatinas Pueden Causar Diabetes
2011-07-05
New Study Suggests High-Dose Statins May Cause Diabetes
2011-06-29
New Study Suggests High-Dose Statins May Cause Diabetes
2011-06-23
FDA Limits Use of 80 mg Simvastatin
2011-06-08
Product Information For Simvastatin (Zocor) and Simvastatin Combined With Ezetimibe (Inegy) Warns About Risks of Muscle Pain and Weakness
2010-06-08
FDA: Ongoing Safety Review of High-Dose Simvastatin (Zocor) and Increased Risk of Muscle Injury
2010-03-19
Statin Benefits Still Outweigh New Safety Information
2010-02-17
Follow-up to the FDA's Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia)
2009-12-23
FDA Issues Final Review of ENHANCE Study
2009-01-09
FDA Is Reviewing Results From a Recent Clinical Trial of Vytorin
2008-08-22
Combination use can lead to rare condition of muscle damage
2008-08-08
Preliminary results from the SEAS trial
2008-07-23
Early communication regarding ongoing FDA review
2008-01-27
See alerts for all drugs